ocular ischemic diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Case group: Patients who diagnosed as ocular ischemic diseases and singed the inform consents. (2) Control group: Age-and gender-matched volunteers who singed the inform consents. (3) Aged 50-70 years. (4) Male or female.
Exclusion criteria
Exclusion criteria: (1) Those without clear FFA images due to refracting media problems such as leukoma, severe cataract, vitreous hemorrhage etc.. (2) Those unable to undergo nuclear magnetic resonance examinations: a. Those with the following devices installed or carried in their body, such as cardiac pacemaker, defibrillator, cardiac stent, artificial heart valve, metal clip after aneurysm operation, drug perfusion device implanted in vivo, any electronic device implanted in vivo (nerve stimulator, bone growth stimulator), intravascular embolization coil, filter, ECG recording monitor, metal suture, bullet or iron granule in vivo, fixed plate after fracture operation, and Steel nails, artificial limbs or joints, hearing aids, cochlear implants, middle ear implants, intraocular metal foreign bodies etc. b. Critical patients who suffer from claustrophobia or obnubilation and forbidden undergoing nuclear magnetic resonance examinations. (3) Those with the history of hemorrhage and cerebral infarction. (4) Those with the history of surgery within 3 months. (5) Those participating in other clinical trials within 3 months. (6) Those who disagree or decline to participate in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vision examination;Visual field examination; | — |
Secondary
| Measure | Time frame |
|---|---|
| Retinal thickness;CVI;ISI; | — |
Countries
China